Janj Fahrenkrug

Janj Fahrenkrug's AcademicInfluence.com Rankings

Janj Fahrenkrug

Biology

#4819

World Rank

#7136

Historical Rank

Neuroscience

#523

World Rank

#543

Historical Rank

biology Degrees

Download Badge

Biology

Janj Fahrenkrug's Degrees

PhD Neuroscience Stanford University

Why Is Janj Fahrenkrug Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Janj Fahrenkrug's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Localization of vasoactive intestinal polypeptide (VIP) to central and peripheral neurons. (1976) (594)
Distribution of vasoactive intestinal polypeptide in the rat and mouse brain (1979) (476)
Neuropeptide expression in rat dorsal root ganglion cells and spinal cord after peripheral nerve injury with special reference to galanin (1989) (464)
Vasoactive intestinal polypeptide in cholinergic neurons of exocrine glands: functional significance of coexisting transmitters for vasodilation and secretion. (1980) (460)
Vagal, cholinergic regulation of pancreatic polypeptide secretion. (1978) (396)
Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide: IUPHAR Review 1 (2012) (376)
Immunohistochemical localization of a vasodilatory polypeptide (VIP) in cerebrovascular nerves (1976) (355)
Vasoactive intestinal polypeptide: measurement, distribution and putative neurotransmitter function. (1979) (329)
The Photopigment Melanopsin Is Exclusively Present in Pituitary Adenylate Cyclase-Activating Polypeptide-Containing Retinal Ganglion Cells of the Retinohypothalamic Tract (2002) (317)
Vasoactive intestinal polypeptide (1980) (310)
Nervous release of vasoactive intestinal polypeptide in the gastrointestinal tract of cats: possible physiological implications. (1978) (298)
Pituitary Adenylate Cyclase-Activating Peptide (PACAP) in the Retinohypothalamic Tract: A Potential Daytime Regulator of the Biological Clock (1997) (292)
Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma. (1978) (284)
Primary sensory neurons of the rat showing calcitonin gene-related peptide immunoreactivity and their relation to substance P-, somatostatin-, galanin-, vasoactive intestinal polypeptide- and cholecystokinin-immunoreactive ganglion cells (1987) (268)
Co-existence of peptide HI (PHI) and VIP in nerves regulating blood flow and bronchial smooth muscle tone in various mammals including man (1984) (254)
DISTRIBUTION OF VASOACTIVE INTESTINAL POLYPEPTIDE (VIP) IN THE PORCINE CENTRAL NERVOUS SYSTEM (1978) (231)
Vasoactive Intestinal Peptide Causes Marked Cephalic Vasodilation, but does not Induce Migraine (2008) (228)
PACAP and glutamate are co‐stored in the retinohypothalamic tract (2000) (227)
Influence of the autonomic nervous system on the release of vasoactive intestinal polypeptide from the porcine gastrointestinal tract. (1978) (203)
Vasoactive intestinal polypeptide occurs in nerves of the female genitourinary tract. (1977) (187)
Gene expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat hypothalamus (1995) (185)
Melanopsin is expressed in PACAP-containing retinal ganglion cells of the human retinohypothalamic tract. (2004) (184)
Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38. (2014) (181)
Vasoactive intestinal polypeptide (VIP): vesicular localization and potassium evoked release from rat hypothalamus (1978) (167)
The PHI (PHI-27)/corticotropin-releasing factor/enkephalin immunoreactive hypothalamic neuron: possible morphological basis for integrated control of prolactin, corticotropin, and growth hormone secretion. (1983) (164)
Peptides in the cat carotid body (glomus caroticum): VIP-, enkephalin-, and substance P-like immunoreactivity. (1979) (157)
On the Role of Galanin, Substance P and Other Neuropeptides in Primary Sensory Neurons of the Rat: Studies on Spinal Reflex Excitability and Peripheral Axotomy (1990) (152)
Dissociation between Light-Induced Phase Shift of the Circadian Rhythm and Clock Gene Expression in Mice Lacking the Pituitary Adenylate Cyclase Activating Polypeptide Type 1 Receptor (2001) (152)
Transmitter role of vasoactive intestinal peptide. (1993) (149)
Target areas innervated by PACAP-immunoreactive retinal ganglion cells (2004) (147)
Penile erection: possible role for vasoactive intestinal polypeptide as a neurotransmitter. (1984) (146)
Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular gland blood flow and secretion. I. VIP release. (1981) (144)
Pituitary adenylate cyclase activating peptide expression in the rat dorsal root ganglia: Up-regulation after peripheral nerve injury (1996) (141)
Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia. (1983) (141)
Vasoactive intestinal polypeptide and cholinergic mechanisms in cat nasal mucosa: studies on choline acetyltransferase and release of vasoactive intestinal polypeptide. (1981) (140)
A rich VIP nerve supply is characteristic of sphincters (1979) (135)
Occurrence of human pancreatic polypeptide in pancreatic endocrine tumors. Possible implication in the watery diarrhea syndrome. (1976) (132)
Diurnal rhythmicity of the clock genes Per1 and Per2 in the rat ovary. (2006) (129)
Reduced corticol choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide (1980) (124)
Diurnal variation of hematology parameters in healthy young males: The Bispebjerg study of diurnal variations (2011) (123)
Neuropeptides as autocrine growth factors in cancer cells. (2003) (123)
Expression of pituitary adenylate cyclase-activating polypeptide in dorsal root ganglia following axotomy: time course and coexistence (1995) (121)
Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular gland blood flow and secretion. II. Effects of cholinergic antagonists and VIP antiserum. (1981) (116)
Melanopsin expressing human retinal ganglion cells: Subtypes, distribution, and intraretinal connectivity (2017) (113)
Nervous control of pancreatic exocrine secretion in pigs. (1979) (113)
Immunohistochemical evidence for a local VIP-ergic neuron system in the adrenal gland of the rat. (1981) (111)
Peptide-containing nerve fibres in the gut wall in Crohn's disease. (1983) (110)
Development of vasoactive intestinal polypeptide (VIP) containing neurones in the rat brain (1979) (109)
Release of vasoactive intestinal polypeptide (VIP) by electric stimulation of the vagal nerves. (1977) (107)
Secretion pattern of secretin in man: regulation by gastric acid. (1978) (107)
Synaptic contact between melanopsin-containing retinal ganglion cells and rod bipolar cells. (2007) (105)
Light and darkness regulate melanopsin in the retinal ganglion cells of the albino wistar rat (2007) (104)
Neuronal VIP in salivary glands: distribution and release. (1980) (103)
Release of vasoactive intestinal polypeptide from the cat small intestine exposed to cholera toxin. (1981) (103)
Innervation of the pancreas by vasoactive intestinal polypeptide (VIP) immunoreactive nerves. (1978) (102)
VIP occurs in intrathyroidal nerves and stimulates thyroid hormone secretion (1980) (101)
Topography of NPY-, somatostatin-, and VIP-immunoreactive, neuronal subpopulations in the guinea pig celiac-superior mesenteric ganglion and their projection to the pylorus (1986) (101)
Peripheral peptide neurons: distribution, axonal transport, and some aspects on possible function. (1980) (101)
Release of vasoactive intestinal polypeptide (VIP) by intraduodenal stimuli. (1977) (101)
Pituitary adenylate cyclase activating polypeptide (PACAP) in the gastrointestinal tract of the rat: distribution and effects of capsaicin or denervation (1997) (98)
Vasoactive intestinal polypeptide (VIP) as a possible neurotransmitter involved in penile erection. (1981) (97)
VIP innervation of the gallbladder. (1977) (97)
Vasoactive intestinal polypeptide induces per1 and per2 gene expression in the rat suprachiasmatic nucleus late at night (2002) (96)
Nasal swell-bodies and cyclic changes in the air passage of the rat and rabbit nose. (1971) (95)
Vasoactive Intestinal Polypeptide Evokes Only a Minimal Headache in Healthy Volunteers (2006) (94)
Analysis of peptide histidine-isoleucine/ vasoactive intestinal polypeptideimmunoreactive neurons in the central nervous system with special reference to their relation to corticotropin releasing factor-and enkephalin-like immunoreactivities in the paraventricular hypothalamic nucleus (1987) (93)
Distribution of galanin-like immunoreactivity in the gastro-intestinal tract of several mammalian species (2004) (92)
Corelease of VIP and acetylcholine in relation to blood flow and salivary secretion in cat submandibular salivary gland (1982) (92)
Pituitary adenylate cyclase activating polypeptide immunoreactivity in capsaicin-sensitive nerve fibres supplying the rat urinary tract (1998) (90)
Vasoactive intestinal polypeptide (VIP) in the pig pancreas: role of VIPergic nerves in control of fluid and bicarbonate secretion (1984) (89)
Subcellular fractionation of cat submandibular gland: Comparative studies on the distribution of acetylcholine and vasoactive intestinal polypeptide (VIP) (1981) (89)
Pituitary adenylate cyclase-activating peptide gene expression in corticotropin-releasing factor-containing parvicellular neurons of the rat hypothalamic paraventricular nucleus is induced by colchicine, but not by adrenalectomy, acute osmotic, ether, or restraint stress. (1995) (89)
Melanopsin containing retinal ganglion cells are light responsive from birth (2004) (88)
Vasoactive intestinal polypeptide (VIP) provokes vaginal lubrication in normal women (1987) (87)
Axonal Transport of Neuropeptides in the Cervical Vagus Nerve of the Rat (1980) (86)
The effects of axotomy and preganglionic denervation on the expression of pituitary adenylate cyclase activating peptide (PACAP), galanin and PACAP type 1 receptors in the rat superior cervical ganglion (1997) (86)
Vasoactive intestinal polypeptide (VIP) as a putative neurotransmitter in penile erection. (1983) (84)
VIP and PHI in cat neurons: co-localization but variable tissue content possible due to differential processing (1985) (82)
Vasoactive intestinal polypeptide and the female genital tract: relationship to reproductive phase and delivery. (1982) (82)
Vasoactive intestinal polypeptide (VIP) in the human female reproductive tract: distribution and motor effects. (1981) (81)
Transient periovulatory expression of pituitary adenylate cyclase activating peptide in rat ovarian cells. (1996) (81)
Vasoactive intestinal polypeptide (VIP): distribution in normal human brain and in Huntington's disease (1979) (80)
The effect of fasting on the hormonal response to graded exercise. (1981) (80)
Corelease of vasoactive intestinal polypeptide and peptide histidine isoleucine in relation to atropine-resistant vasodilation in cat submandibular salivary gland (1984) (79)
Evidence for involvement of nitric oxide in the regulation of hypothalamic portal blood flow (1992) (79)
Pituitary Adenylate Cyclase‐Activating Peptide in Sensory and Autonomic Ganglia: Localization and Regulation a (1996) (76)
Vasoactive intestinal polypeptide (VIP) in human cerebrospinal fluid (1977) (76)
Pituitary adenylate cyclase-activating polypeptide induces period1 and period2 gene expression in the rat suprachiasmatic nucleus during late night (2001) (75)
The effect of intravenous PACAP38 on cerebral hemodynamics in healthy volunteers (2007) (74)
Radioimmunoassay of secretin in plasma. (1977) (74)
Melanopsin: a novel photopigment involved in the photoentrainment of the brain's biological clock? (2002) (74)
Diurnal Rhythmicity of the Canonical Clock Genes Per1, Per2 and Bmal1 in the Rat Adrenal Gland is Unaltered after Hypophysectomy (2008) (73)
Extensive Monitoring Through Multiple Blood Samples in Professional Soccer Players (2013) (72)
Development and validation of a specific radioimmunoassay for PHI in plasma. (1984) (72)
Gastroenteropancreatic hormonal changes during exercise. (1980) (70)
Neurotensin-like immunoreactivities in human plasma: Feeding responses and metabolism (1986) (70)
Characteristics of the axonal transport of vasoactive intestinal polypeptide (VIP) in nerves of the cat. (1981) (70)
Vasoactive intestinal polypeptide: functional aspects. (1982) (68)
Global but not gonadotrope-specific disruption of Bmal1 abolishes the luteinizing hormone surge without affecting ovulation. (2013) (67)
The Imprinted Gene Neuronatin Is Regulated by Metabolic Status and Associated With Obesity (2010) (66)
Physiological significance of secretin in the pancreatic bicarbonate secretion. I. Responsiveness of the secretin-releasing system in the upper duodenum. (1979) (66)
Neuronal localization of pituitary adenylate cyclase-activating polypeptide 38 in the adrenal medulla and growth-inhibitory effect on chromaffin cells (1995) (66)
VIP and PHI in the pig pancreas: coexistence, corelease, and cooperative effects. (1987) (66)
Vasoactive intestinal polypeptide (VIP) in the male genitourinary tract: concentration and motor effect. (1981) (65)
Secretory effects of VIP on isolated perfused porcine pancreas. (1978) (65)
Intracavernous self-injection with vasoactive intestinal polypeptide and phentolamine in the management of erectile failure. (1992) (65)
VIP and autonomic neurotransmission. (1989) (65)
Distribution and motor effect of VIP in female genital tract. (1981) (65)
Expression of pituitary adenylate cyclase activating polypeptide (PACAP) gene by rat spermatogenic cells (1995) (64)
Increase in vagal activity during hypotensive lower-body negative pressure in humans. (1988) (63)
Molecular fingerprint of neuropeptide s‐producing neurons in the mouse brain (2011) (63)
Neuronal input pathways to the brain's biological clock and their functional significance. (2005) (63)
Light-Dependent Induction of cFos during Subjective Day and Night in PACAP-Containing Ganglion Cells of the Retinohypothalamic Tract (2001) (63)
Vasoactive intestinal polypeptidergic nerves and Brunner's gland secretion in the rat. (1981) (62)
Peptidergic (VIP) nerves in the mammalian choroid plexus (1978) (62)
PHI, a VIP-like peptide, is present in the rat median eminence. (1982) (62)
Pituitary Adenylate Cyclase Activating Peptide (PACAP) in the Retinohypothalamic Tract: A Daytime Regulator of the Biological Clock a (1998) (62)
Nervous control of pancreatic endocrine secretion in pigs. I. Insulin and glucagon responses to electrical stimulation of the vagus nerves. (1981) (61)
Insulin receptors in rat brain cortex. Kinetic evidence for a receptor subtype in the central nervous system (1984) (60)
Vasoactive intestinal polypeptide, 5‐hydroxytryptamine and reflex hyperaemia in the small intestine of the cat (1980) (60)
Pituitary Adenylate Cyclase-Activating Polypeptide Is an Auto/Paracrine Stimulator of Acute Progesterone Accumulation and Subsequent Luteinization in Cultured Periovulatory Granulosa/Lutein Cells. (1999) (60)
The circadian photopigment melanopsin is expressed in the blind subterranean mole rat, Spalax (2002) (60)
Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) in the mesencephalic trigeminal nucleus of the rat after transsection of the masseteric nerve. (1997) (58)
Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular gland blood flow and secretion. (1982) (57)
Coexistence of CGRP- and VIP-like immunoreactivities in a population of neurons in the cat stellate ganglia. (1987) (57)
The regional distribution of receptors for vasoactive intestinal polypeptide (VIP) in the rat central nervous system (1985) (56)
High levels of vasoactive intestinal peptide in human milk. (1985) (56)
Mice lacking the PACAP type I receptor have impaired photic entrainment and negative masking. (2008) (55)
Meal-stimulated secretin release in man: effect of acid and bile. (1981) (54)
VIP as a mediator of hexamethonium-sensitive, atropine-resistant vasodilation in the cat tongue. (1982) (54)
Pituitary adenylate cyclase‐activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum (1995) (53)
Innervation pattern and Ca2+ signalling in labial salivary glands of healthy individuals and patients with primary Sjögren's syndrome (pSS). (2000) (53)
Secretory effects of secretin on isolated perfused porcine pancreas. (1978) (53)
Absence of Vasoactive Peptide Release from Brain to Cerebral Circulation During Onset of Migraine With Aura (1994) (53)
Altered Expression Pattern of Clock Genes in a Rat Model of Depression (2016) (53)
VIP STIMULATES PROLACTIN RELEASE IN WOMEN (1981) (52)
Pancreatic response and plasma secretin concentration during infusion of low dose secretin in man. (1978) (52)
Period1 gates the circadian modulation of memory‐relevant signaling in mouse hippocampus by regulating the nuclear shuttling of the CREB kinase pP90RSK (2016) (52)
Pituitary adenylate cyclase-activating polypeptide in intrinsic and extrinsic nerves of the rat pancreas (1999) (51)
The effect of galanin, CGRP and ANP on spontaneous smooth muscle activity of rat uterus (1988) (51)
VASOACTIVE INTESTINAL POLYPEPTIDE RELEASE DURING PENILE ERECTION IN MAN (1982) (49)
Contents and effects of substance P and vasoactive intestinal polypeptide in the bladder of rats with and without infravesical outflow obstruction. (1988) (49)
Embryonic expression of pituitary adenylate cyclase‐activating polypeptide in sensory and autonomic ganglia and in spinal cord of the rat (1998) (49)
PACAP—A Multifacetted Neuropeptide (2006) (49)
Pituitary adenylate cyclase-activating peptide (PACAP) and PACAP type 1 receptor expression in regenerating adult mouse and rat superior cervical ganglia in vitro (1997) (49)
Decreased VIP and VPAC2 receptor expression in the biological clock of the R6/2 Huntington's disease mouse (2007) (48)
Pituitary adenylate cyclase-activating polypeptide: occurrence and relaxant effect in female genital tract. (1995) (48)
PreproPACAP-derived peptides occur in VIP-producing tumours and co-exist with VIP (1995) (48)
Pituitary adenylate cyclase activating polypeptide innervation of the rat female reproductive tract and the associated paracervical ganglia: Effect of capsaicin (1996) (48)
Plasma secretin concentration and pancreatic exocrine secretion after intravenous secretin or intraduodenal HC1 in anaesthetized pigs. (1977) (48)
Identification of pituitary adenylate cyclase-activating polypeptide1-38-binding factor in human plasma, as ceruloplasmin. (1999) (48)
PACAP-(1-38) as neurotransmitter in pig pancreas: receptor activation revealed by the antagonist PACAP-(6-38). (1997) (48)
Nervous control of pancreatic endocrine secretion in pigs. II. The effect of pharmacological blocking agents on the response to vagal stimulation. (1981) (48)
Neurotransmitters co-existing with VIP or PACAP (2004) (48)
Plasma secretin concentration in man: effect of intraduodenal glucose, fat, amino acids, ethanol, HCI, or ingestion of a meal (1977) (47)
Diurnal Variations of Human Circulating Cell-Free Micro-RNA (2016) (47)
Expression of melanopsin during development of the rat retina (2004) (47)
Immunoreactive Calcitonin Gene‐Related Peptide, Vasoactive Intestinal Polypeptide, and Somatostatin in Developing Chicken Spinal Cord Motoneurons (1989) (47)
Vasoactive intestinal polypeptide and other preprovasoactive intestinal polypeptide-derived peptides in the female and male genital tract: localization, biosynthesis, and functional and clinical significance. (1995) (47)
Existence and coexistence of calcitonin gene-related peptide, vasoactive intestinal polypeptide- and somatostatin-like immunoreactivities in spinal cord motoneurons of developing embryos and post-hatch chicks (1988) (47)
Neuropeptides in the female genital tract: Effect on vascular and non-vascular smooth muscle (1983) (45)
Temporal phasing of locomotor activity, heart rate rhythmicity, and core body temperature is disrupted in VIP receptor 2-deficient mice. (2011) (45)
Receptors for vasoactive intestinal polypeptide on crude smooth muscle membranes from porcine uterus. (1982) (45)
pH threshold for release of secretin in normal subjects and in patients with duodenal ulcer and patients with chronic pancreatitis. (1978) (45)
Light‐induced phase shift in the Syrian hamster (Mesocricetus auratus) is attenuated by the PACAP receptor antagonist PACAP6‐38 or PACAP immunoneutralization (2003) (44)
Vasoactive intestinal polypeptide (VIP) in cirrhosis: arteriovenous extraction in different vascular beds. (1980) (43)
Cholecystokinin and vasoactive intestinal polypeptide in the mammalian CNS: distribution and possible physiological roles. (1980) (43)
Concentration of immunoreactive trypsin and activity of pancreatic isoamylase in serum compared in pancreatic diseases. (1980) (43)
A pancreatic-polypeptide-producing tumour associated with the WDHA syndrome. (1978) (43)
Peptide histidine methionine and vasoactive intestinal peptide: occurrence and relaxant effect in the human female reproductive tract. (1989) (43)
Loss of Melanopsin-Expressing Retinal Ganglion Cells in Severely Staged Glaucoma Patients. (2016) (43)
The mechanism of hypergastrinemia in achlorhydria. Effect of food, acid, and calcitonin on serum gastrin concentrations and component pattern in pernicious anemia, with correlation to endogenous secretin concentrations in plasma. (1976) (43)
Secretory effects of cholecystokinins on the isolated perfused porcine pancreas. (1981) (42)
Vesicular glutamate transporter 2 (VGLUT2) is co-stored with PACAP in projections from the rat melanopsin-containing retinal ganglion cells (2010) (42)
Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients (2017) (42)
Circadian clock components in the rat neocortex: daily dynamics, localization and regulation (2013) (42)
Fat-induced jejunal inhibition of gastric acid secretion and release of pancreatic glucagon, enteroglucagon, gastric inhibitory polypeptide, and vasoactive intestinal polypeptide in man. (1979) (42)
Distribution and effects of pituitary adenylate cyclase activating peptide in cat and human lower oesophageal sphincter (1995) (41)
Effect of vasoactive intestinal polypeptide (VIP) upon myometrial blood flow in non-pregnant rabbit. (1981) (41)
VIP and PACAP. (2010) (41)
Rhythmic 24-hour variations of frequently used clinical biochemical parameters in healthy young males – The Bispebjerg study of diurnal variations (2012) (40)
Substance P-, VIP- and CGRP-like immunoreactivities coexist in a population of cholinergic postganglionic sympathetic nerves innervating sweat glands in the cat. (1988) (40)
Pituitary adenylate cyclase activating polypeptide (PACAP): occurrence and vasodilatory effect in the human uteroplacental unit (1996) (40)
PACAP Gene Expression in Neurons of the Rat Hypothalamo-Pituitary-Adrenocortical Axis Is Induced by Endotoxin and Interleukin-1β (1999) (40)
Regulation of behavioral circadian rhythms and clock protein PER1 by the deubiquitinating enzyme USP2 (2012) (40)
Effect of VIP infusion in water and ion transport in the human jejunum. (1980) (39)
Release of oxytocin and vasopressin by intracerebroventricular vasoactive intestinal polypeptide. (1988) (39)
PACAP in hypothalamic regulation of sleep and circadian rhythm: importance for headache (2018) (39)
The CSF and arterial to internal jugular venous hormonal differences during exercise in humans (2004) (39)
A disulfide bond between conserved cysteines in the extracellular loops of the human VIP receptor is required for binding and activation (1997) (38)
A long ascending projection in the rat brain containing vasoactive intestinal polypeptide (1981) (38)
Calcitonin-gene related peptide and disease activity in cluster headache (2019) (37)
Circadian Behaviour in Neuroglobin Deficient Mice (2012) (37)
Co-existence and co-secretion of the structurally related peptides VIP and PHI. (1987) (37)
Further analysis of presence of peptides in dopamine neurons (1988) (37)
Differential expression of melanopsin mRNA and protein in Brown Norwegian rats. (2013) (37)
Vasoactive intestinal polypeptide in vagally mediated pancreatic secretion of fluid and HCO3. (1979) (37)
Nervous release of vasoactive intestinal polypeptide from the feline uterus: pharmacological characteristics. (1982) (37)
VIP (vasoactive intestinal polypeptide)-containing nerves of intracranial arteries in mammals (2004) (36)
Substance P effects on blood flow, fluid transport and vasoactive intestinal polypeptide release in the feline small intestine. (1995) (36)
Vasoactive intestinal peptide (VIP) stimulates oxytocin and vasopressin release from the neurohypophyis. (1984) (36)
Vasoactive intestinal polypeptide (VIP) in epithelial cells of the gut mucosa of an elasmobranchian cartilaginous fish, the ray. (1980) (36)
Circulating endogenous vasoactive intestinal polypeptide (VIP) in patients with uraemia and liver cirrhosis (1986) (35)
Immunoreactive trypsin and pancreatic isoamylase activity in serum of patients with chronic renal failure or hepatic cirrhosis. (1981) (35)
Fasting and prolonged exercise increase vasoactive intestinal polypeptide (VIP) in plasma. (1979) (35)
VIP and PACAP display different vasodilatory effects in rabbit coronary and cerebral arteries (2003) (35)
Occurrence of VIP and peptide HM in human pancreas and their influence on pancreatic endocrine secretion in man (1987) (35)
VASOACTIVE INTESTINAL POLYPEPTIDE AND HUMAN VAGINAL BLOOD FLOW: COMPARISON BETWEEN TRANSVAGINAL AND INTRAVENOUS ADMINISTRATION (1990) (35)
Report on a patient with watery diarrhoea syndrome caused by a pancreatic tumour containing neurotensin, enkephalin and calcitonin. (2009) (35)
On the VIP-ergic innervation of the feline pylorus. (1979) (35)
Pituitary adenylate cyclase activating polypeptide (PACAP) in the rat mammary gland (1999) (34)
Innervation of the rat pineal gland by pituitary adenylate cyclase-activating polypeptide (PACAP)-immunoreactive nerve fibres (1999) (34)
Pituitary adenylate cyclase activating peptide (PACAP) mRNA in the rat neocortex (1994) (34)
Loss of Melanopsin-Expressing Retinal Ganglion Cells in Patients With Diabetic Retinopathy. (2017) (33)
PACAP-(1-38) as neurotransmitter in the porcine adrenal glands. (2000) (33)
Vasoactive intestinal polypeptide (VIP) inhibits oxytocin induced activity of the rabbit myometrium. (1979) (33)
Vasoactive intestinal polypeptide/peptide histidine isoleucine immunoreactive neuron systems in the basal hypothalamus of the rat with special reference to the portal vasculature: An immunohistochemical and in situ hybridization study (1991) (33)
Dementia of different etiologies (1985) (32)
Melanopsin changes in neonatal albino rat independent of rods and cones (2007) (32)
Preparation of 125I-labeled synthetic porcine secretin for radioimmunoassay. (1976) (31)
Somatostatin and methionine-enkephalin inhibit cholera toxin-induced jejunal net fluid secretion and release of vasoactive intestinal polypeptide in the cat in vivo. (1988) (31)
Concentrations and distribution of vasoactive intestinal peptide (VIP), peptide histidine isoleucine (PHI) and peptide histidine valine (PHV) in the cerebral cortex and the suprachiasmatic nucleus of the mouse (1994) (31)
Interrelation of nerves and hormones in stomach and pancreas. (1983) (31)
Vasoactive intestinal polypeptide decreased in cerebrospinal fluid (CSF) in atypical depression. Vasoactive intestinal polypeptide, cholecystokinin and gastrin in CSF in psychiatric disorders. (1984) (31)
Nervous control of pancreatic endocrine secretion in pigs. III. The effect of acetylcholine on the pancreatic secretion of insulin and glucagon. (1981) (30)
Effect of calcitonin on serum gastrin concentration and component pattern in man. (1975) (30)
Peptidergic (VIP) nerves in the pancreas (1978) (30)
Production and evaluation of antibodies for radioimmunoassay of secretin. (1976) (30)
Neuropeptide Y, enkephalin and noradrenaline coexist in sympathetic neurons innervating the bovine spleen (1986) (30)
PACAP 1–38 as neurotransmitter in the porcine antrum (2001) (30)
Neuroglobin expression in the rat suprachiasmatic nucleus: Colocalization, innervation, and response to light (2010) (30)
Increased expression, axonal transport and release of pituitary adenylate cyclase-activating polypeptide in the cultured rat vagus nerve (1999) (30)
Release of immunoreactive vasoactive intestinal peptide (VIP) from the gallbladder in response to vagal stimulation. (1986) (29)
The effect of splanchnic nerve stimulation and neuropeptide Y on cholera secretion and release of vasoactive intestinal polypeptide in the feline small intestine. (1988) (29)
Characterization and Regional Distribution of Peptides Derived from the Vasoactive Intestinal Peptide Precursor in the Normal Human Brain (1989) (29)
Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma. (1977) (28)
Ependymal and neuronal specializations in the lateral ventricle of the Pekin duck, Anas platyrhynchos (2004) (28)
Preparation of 125I-(Tyr 3)- and 125I-(Tyr 11)- neurotensin for radioimmunoassay. (1983) (28)
Altered Rhythm of Adrenal Clock Genes, StAR and Serum Corticosterone in VIP Receptor 2-Deficient Mice (2012) (28)
Vasoactive intestinal polypeptide loses its ability to increase vaginal blood flow after menopause. (1991) (27)
USP2 Regulates the Intracellular Localization of PER1 and Circadian Gene Expression (2014) (27)
Distribution and regional variation of pituitary adenylate cyclase activating polypeptide and other neuropeptides in the rat urinary bladder and ureter: effects of age (2002) (27)
Peptide histidine valine (PHV) is present and biologically active in the human female genital tract (1992) (27)
Secretin and the Zollinger--Ellison syndrome: reliability of secretin tests and pathogenetic role of secretin. (1978) (27)
Effect of apamin on release of vasoactive intestinal polypeptide (VIP) from the cat intestines. (1983) (26)
Vasoactive intestinal polypeptide (VIP) inhibits prostaglandin-F2 alpha-induced activity of the rabbit myometrium. (1980) (26)
Evidence for common precursors but differential processing of VIP and PHM in VIP-producing tumors (1985) (26)
Restricted expression of Neuroglobin in the mouse retina and co-localization with Melanopsin and Tyrosine Hydroxylase. (2012) (26)
Density of peptide histidine‐isoleucine‐ and vasoactive intestinal peptide‐immunoreactive nerve fibers in the sheep pineal gland is not affected by superior cervical ganglionectomy (1994) (26)
Distribution, ontogeny and ultrastructure of the mammalian secretin cell (1977) (26)
Neurotensin inhibits meal-stimulated gastric acid secretion in man. (1983) (26)
Nervous control of pancreatic endocrine secretion in pigs. V. Influence of the sympathetic nervous system on the pancreatic secretion of insulin and glucagon, and on the insulin and glucagon response to vagal stimulation. (1981) (26)
Photic induction of c-Fos in enkephalin neurons of the rat intergeniculate leaflet innervated by retinal PACAP fibres (2007) (25)
Neuropeptide Y: presence in sympathetic and parasympathetic innervation of the nasal mucosa (2004) (25)
Cranial parasympathetic activation induces autonomic symptoms but no cluster headache attacks (2018) (25)
Chamber-dependent circadian expression of cardiac natriuretic peptides (2010) (25)
On the VIP-ergic innervation of the uterotubal junction. (1981) (25)
Physiological significance of secretin in the pancreatic bicarbonate secretion. II. Pancreatic bicarbonate response to a physiological increase in plasma secretin concentration. (1979) (24)
Increased myometrial blood flow evoked by vasoactive intestinal polypeptide in the non‐pregnant goat (1981) (24)
Effect of Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide on Pancreatic, Hepatic and Duodenal Mucosal Bicarbonate Secretion in the Pig (2003) (24)
Diurnal plasma concentrations of natriuretic propeptides in healthy young males. (2012) (24)
Hypersecretion of calcitonin in patients with the Verner-Morrison syndrome. (1981) (24)
Plasma β-endorphin during clinical and experimental ischaemic pain (1987) (24)
On the Role of Substance P, Galanin, Vasoactive Intestinal Peptide, and Calcitonin Gene—related Peptide in Mediation of Spinal Reflex Excitability in Rats with Intact and Sectioned Peripheral Nerves a (1991) (24)
Hair dyeing, hair washing and hair cortisol concentrations among women from the healthy start study (2017) (23)
Immunoreactive substance P is not part of the retinohypothalamic tract in the rat (2002) (23)
Regulatory peptides in the mammalian urogenital system. (1989) (23)
Vasoactive intestinal polypeptide (VIP) and peptide histidine methionine (PHM) in human penile corpus cavernosum tissue and circumflex veins: localization and in vitro effects (1992) (23)
Association between Hair Cortisol Concentration and Adiposity Measures among Children and Parents from the “Healthy Start” Study (2016) (22)
Mechanisms of neurotensin-induced fluid secretion in the cat ileum in vivo. (1987) (22)
Expression of the clock genes Per1 and Bmal1 during follicle development in the rat ovary. Effects of gonadotropin stimulation and hypophysectomy (2012) (22)
Plasma concentration of vasoactive intestinal polypeptide during prolonged physical exercise, calorie supply deficiency, and sleep deprivation. (1983) (22)
Influence of pregnancy and sex steroids on concentration, motor effect and receptor binding of VIP in the rabbit female genital tract (1985) (22)
Pituitary Adenylate Cyclase-Activating Peptide Stimulates Acute Progesterone Production in Rat Granulosa/Lutein Cells via Two Receptor Subtypes1 (2000) (22)
Neuropeptides in the Regulation of Female Genital Smooth Muscle Contractility (1983) (22)
Expression of preproVIP-derived peptides in the human gastrointestinal tract: a biochemical and immunocytochemical study (1991) (21)
Secretory effects of gastrins on isolated perfused porcine pancreas. (1980) (21)
Diurnal changes of biochemical metabolic markers in healthy young males – the Bispebjerg study of diurnal variations (2015) (21)
Multiplicity of receptors for vasoactive intestinal polypeptide (VIP): Differential effects of apamin on binding in brain, uterus and liver (1983) (21)
Proposed arrangement of the seven transmembrane helices in the secretin receptor family. (1998) (21)
Peptides PHI and VIP: comparison between vascular and nonvascular smooth muscle effect in rabbit uterus. (1986) (21)
Cosecretion of peptide histidine methionine (PHM) and vasoactive intestinal peptide (VIP) in patients with VIP-producing tumors (1986) (21)
Altered pupillary light reflex in PACAP receptor 1-deficient mice (2012) (20)
Serotonin inhibits glutamate‐ but not PACAP‐induced per gene expression in the rat suprachiasmatic nucleus at night (2003) (20)
Hypophysectomy abolishes rhythms in rat thyroid hormones but not in the thyroid clock (2017) (20)
Altered calmodulin response to light in the suprachiasmatic nucleus of PAC1 receptor knockout mice revealed by proteomic analysis (2007) (20)
Plasma secretin concentration in anaesthetized pigs after intraduodenal glucose, fat, aminoacids, or meals with various pH. (1977) (20)
Expression of pituitary adenylate cyclase activating peptide in the uterine cervix, lumbosacral dorsal root ganglia and spinal cord of rats during pregnancy (2006) (20)
Infusion of vasoactive intestinal polypeptide in man: pharmacokinetics and effect on gastric acid secretion. (1981) (20)
Streptozotocin treatment of a pancreatic tumour producing VIP and gastrin associated with Verner-Morrison syndrome. (2009) (19)
Localisation of the neuropeptide PACAP and its receptors in the rat parathyroid and thyroid glands. (2011) (19)
PAC1- and VPAC2 receptors in light regulated behavior and physiology: Studies in single and double mutant mice (2017) (19)
Evaluation of Serum Insulin-like Factor 3 Quantification by LC-MS/MS as a Biomarker of Leydig Cell Function. (2020) (19)
N-linked deglycosylated melanopsin retains its responsiveness to light. (2009) (19)
Effect of secretin on basal- and glucose-stimulated insulin secretion in man (1978) (19)
Non-amidated forms of VIP (glycine-extended VIP and VIP-free acid) have full bioactivity on smooth muscle (1989) (19)
On the role of vasoactive intestinal polypeptide and tachykinins in the secretory reflex elicited by chemical peritonitis in the cat small intestine. (1990) (19)
The presence of vasoactive intestinal polypeptide (VIP)-like-immunoreactive nerve fibres and VIP-receptors in the pineal gland of the Mongolian gerbil (Meriones unguiculatus) (1985) (18)
VIP in cerebrospinal fluid of patients with multiple sclerosis (1984) (18)
Diurnal variation of von Willebrand factor in plasma: the Bispebjerg study of diurnal variations (2014) (18)
Retinoic acid down-regulates the expression of the vasoactive intestinal polypeptide receptor type-1 in human breast carcinoma cell lines. (1998) (18)
VASOACTIVE INTESTINAL POLYPEPTIDE (VIP)‐PRODUCING GANGLIONEUROMA IN A CHILD WITH CHRONIC DIARRHEA (1980) (18)
High affinity receptors for vasoactive intestinal peptide on a human glioma cell line (1990) (18)
Homer-1 mRNA in the rat suprachiasmatic nucleus is regulated differentially by the retinohypothalamic tract transmitters pituitary adenylate cyclase activating polypeptide and glutamate at time points where light phase-shifts the endogenous rhythm. (2002) (18)
Glycine-extended processing intermediate of proVIP: a new form of VIP in the rat. (1991) (17)
VIP receptors in pig liver cells: Binding characteristics and role in degradation (1984) (17)
The presence of nerve fibers immunoreactive for vasoactive intestinal peptide (VIP), peptide histidine isoleucine (PHI), and preproVIP(111–122) in the mouse pineal gland (1994) (17)
Signaling pathways in PACAP regulation of VIP gene expression in human neuroblastoma cells (2009) (17)
Cellular localization and ontogeny of immunoreactive Vasoactive intestinal polypeptide (VIP) in the chicken gut (1979) (16)
Characterization of the effects of retinoic acid on vasoactive intestinal polypeptide gene expression in neuroblastoma cells. (1994) (16)
Gut/brain peptides in the genital tract: VIP and PACAP (2001) (16)
Pituitary adelylate cyclase-activating peptide is an activator of vasoactive intestinal polypeptide gene transcription in human neuroblastoma cells. (2000) (16)
Neurotensin induced inhibition of gastric acid secretion in duodenal ulcer patients before and after parietal cell vagotomy. (1984) (16)
Lack of the PAC1 receptor alters the circadian expression of VIP mRNA in the suprachiasmatic nucleus of mice (2007) (16)
Prepro-Vasoactive Intestinal Polypeptide-Derived Peptide Sequences in Cerebral Blood Vessels of Rats: On the Functional Anatomy of Metabolic Autoregulation (1991) (16)
Creation of a selective antagonist and agonist of the rat VPAC(1) receptor using a combinatorial approach with vasoactive intestinal peptide 6-23 as template. (2000) (16)
Phosphorylation of Rat Melanopsin at Ser-381 and Ser-398 by Light/Dark and Its Importance for Intrinsically Photosensitive Ganglion Cells (ipRGCs) Cellular Ca2+ Signaling* (2014) (15)
Circulating levels of vasoactive peptides in patients with acute bacterial meningitis (2009) (15)
Effect of thyroid hormones on vasoactive intestinal polypeptide gene expression in the rat cerebral cortex and anterior pituitary (1995) (15)
Vip Increases in Nasal Blood During Stimulation of the Vidian Nerve (1981) (14)
PreproVIP-derived peptides in the human female genital tract: expression and biological function (1997) (14)
Role of pituitary adenylate cyclase-activating peptide (PACAP) in the cyclic recruitment of immature follicles in the rat ovary (2005) (14)
Pituitary adenylate cyclase‐activating polypeptide promotes eccrine gland sweat secretion (2017) (14)
Epithelial cells purified from choroid plexus have receptors for vasoactive intestinal polypeptide (1991) (14)
Meal stimulated levels of pancreatic polypeptide (PP) and vasoactive intestinal polypeptide (VIP) in gastroplasty for morbid obesity (1985) (13)
Neuropeptides and neural cell adhesion molecule (NCAM) in CSF from patients with ALS (1989) (13)
The effect of vasoactive intestinal polypeptide on meal-stimulated gastric acid secretion in man. (1983) (13)
Regulatory Peptides and Uterine Function (1990) (13)
Vasoactive intestinal polypeptide and peptide histidine methionine. Presence in human follicular fluid and effects on DNA synthesis and steroid secretion in cultured human granulosa/lutein cells. (1994) (13)
Light induces Fos expression via extracellular signal‐regulated kinases 1/2 in melanopsin‐expressing PC12 cells (2010) (13)
Functional expression of rat VPAC1 receptor in Saccharomyces cerevisiae. (1999) (13)
Characterization of a G protein coupling “YL” motif of the human VPAC1 receptor, equivalent to the first two amino acids in the “DRY” motif of the rhodopsin family (2001) (13)
Vasoactive Intestinal Polypeptide (VIP): Specific Receptors on Smooth Muscle Membranes from Porcine Uterus (1982) (13)
PreproVIP‐derived peptides in tissue and plasma from patients with VIP‐producing tumours (1991) (13)
Altered Circadian Food Anticipatory Activity Rhythms in PACAP Receptor 1 (PAC1) Deficient Mice (2016) (13)
Plasma insulin concentration during physiological variations in immunoreactive plasma secretin. (1976) (13)
Prenatal Expression of Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) in Autonomic and Sensory Ganglia and Spinal Cord of Rat Embryos a (1998) (13)
Expression of eight neuropeptides in intraocular spinal cord grafts: Organotypical and disturbed patterns as evidenced by immunohistochemistry (1988) (13)
Mice Lacking EGR1 Have Impaired Clock Gene (BMAL1) Oscillation, Locomotor Activity, and Body Temperature (2017) (12)
Role of vasoactive intestinal polypeptide (VIP) in the neurogenic vasodilatation of the portal vein in the rabbit (1985) (12)
Vasoactive Intestinal Polypeptide and the Reproductive System (1988) (12)
Diurnal Variation of Markers for Cholesterol Synthesis, Cholesterol Absorption, and Bile Acid Synthesis: A Systematic Review and the Bispebjerg Study of Diurnal Variations (2019) (12)
Immunocytochemical localisation of pancreastatin and chromogranin A in porcine neuroendocrine tissues (1991) (12)
Vasoactive Intestinal Polypeptide in Human Cerebrospinal Fluid (1981) (12)
Expression of prepro-VIP derived peptides in the gastrointestinal tract of normal, hypothyroid and hyperthyroid rats (1996) (12)
Vasoactive intestinal peptide in the normal and inflamed feline gallbladder (1989) (11)
Some blood vessels in the rat median eminence are surrounded by a dense plexus of vasoactive intestinal polypeptide/peptide histidine isoleucine (VIP/PHI) immunoreactive nerves (1988) (11)
Effect of vasoactive intestinal polypeptide (VIP) on steroidogenesis in women (1986) (11)
Plasma-VIP and Plasma-Substance-P during Migraine-Attack (1985) (11)
Glutamic acid decarboxylase‐ and peptide‐immunoreactive neurons in cortex cerebri following development in isolation: Evidence of homotypic and disturbed patterns in intraocular grafts (1987) (11)
Effects of age and streptozotocin-induced diabetes on contents and effects of substance P and vasoactive intestinal polypeptide in the lower urinary tract of the rat. (1992) (11)
Circadian regulation of protein cargo in extracellular vesicles (2022) (11)
Characterization of immunoreactive pancreastatin in porcine tissues. (1991) (11)
Cholecystokinin (CCK)‐expressing neurons in the suprachiasmatic nucleus: innervation, light responsiveness and entrainment in CCK‐deficient mice (2010) (11)
Pituitary adenylate cyclase activating polypeptide (PACAP) in human ovarian cancers. (1998) (11)
VIP binding sites on synaptosomes from rat cerebral cortex: Structure-binding relationship (1986) (11)
Circadian rhythm regulation: a central role for the neuropeptide vasoactive intestinal polypeptide. (2003) (11)
Release of vasoactive intestinal polypeptide anally of a local distension of the feline small intestine. (1987) (11)
Effects of acute and long-term atropine treatment on levels, release and response to VIP and PHI in the submandibular gland of cat and rat. (1992) (11)
Chemical Neuroanatomy of the Hypothalamo-Pituitary Axis: Focus on Multimessenger Systems (1987) (11)
Peptide histidine methionine (PHM) increases vaginal blood flow in normal women (1990) (11)
Secretin and Vasoactive Intestinal Polypeptide in the Control of the Endocrine Pancreas1 (1980) (11)
Elimination of porcine secretin in pigs. (1978) (11)
A peptide with N-terminal histidine and C-terminal isoleucine amide (PHI) and vasoactive intestinal peptide (VIP) are copackaged in myenteric neurones of the guinea pig ileum (1989) (10)
Multiple blood samples in elite soccer players. Is it worthwhile? (2014) (10)
Effects of VIP in the female genital tract. (1980) (9)
Neuropeptides with vascular activity: VIP, PHI, NPY and substance P. (1984) (9)
Somatostatin Inhibits Neurally Stimulated Pancreatic Secretion Indirectly (1990) (9)
Estradiol down regulates expression of vasoactive intestinal polypeptide receptor type-1 in breast cancer cell lines (2001) (9)
Effects of intra-arterially infused adenosine triphosphate (ATP) on release of vasoactive intestinal polypeptide (VIP) from the gastrointestinal tract of the cat. (1985) (8)
Cholinergic regulation of VIP gene expression in human neuroblastoma cells (1997) (8)
Serum calcitonin in hypergastrinaemia due to achlorhydria. (1977) (8)
Expression and characterization of preproVIP derived peptides in the human male urogenital tract (1995) (8)
Expression and characterization of VIP and two VIP mutants in NIH 3T3 cells (1994) (8)
On the origin and distribution of vasoactive intestinal polypeptide-, peptide HI-, and cholecystokinin-like-immunoreactive nerve fibers in the rat iris (2004) (8)
Glycine-extended processing intermediate of proVIP: A new bioactive form of VIP (1992) (8)
Neuropeptides in Human Brain: Studies on Substance P, Cholecystokinin, Vasoactive Intestinal Polypeptide and Methionine-Enkephalin in Normal Human Brain and in Huntington Disease (1981) (7)
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) in the circulation after sumatriptan (2013) (7)
Serum immunoreactive trypsin, pancreatic polypeptide, and pancreatic isoamylase as diagnostic tests for chronic pancreatitis. (1984) (7)
Development of binding sites for vasoactive intestinal polypeptide in mouse cerebral cortex and cultured cortical neurons (1985) (7)
Circadian variations in plasma concentrations of cholecystokinin and gastrin in man (2020) (7)
Do concentrations of neurotransmitters measured in lumbar cerebrospinal fluid reflect the concentrations at brain level? (2005) (7)
Verner-Morrison syndrome and vasoactive intestinal polypeptide (VIP). (1979) (6)
Neurotransmitter-role of VIP in non-adrenergic relaxation of feline myometrium (1986) (6)
All prepro-VIP-derived peptides, except PHI PHV , are expressed in the female rat anterior pituitary and increased by estrogen (1995) (6)
Do substance P and vasoactive intestinal polypeptide (VIP) play a role in the acute occlusive or chronic ischaemic vasodilation in man? (1986) (6)
Calmodulin interacts with PAC1 and VPAC2 receptors and regulates PACAP-induced FOS expression in human neuroblastoma cells (2009) (6)
Secretion of pancreastatins from the porcine digestive tract. (1994) (6)
Immunohistochemical studies on the CNS using antisera to VIP and PHI and some functional aspects (1983) (6)
Characterization and content of VIP and VIP mRNA in rat fore-brain neurones (1994) (5)
Location of PHM/VIP mRNA in human gastrointestinal tract detected by in situ hybridization (1994) (5)
Vasoactive intestinal polypeptide: Specific binding to purified synaptic membranes from rat brain (1980) (5)
Insulin receptors in rat brain (1983) (5)
Peptide histidine-isoleucine (PHI)-immunoreactive amacrine cells in the retina of the rat (1987) (5)
Role of second extracellular loop in the function of human vasoactive intestinal polypeptide/pituitary adenylate cyclase activating polypeptide receptor 1 (hVPAC1R) (2000) (5)
Secretin does not inhibit glucagon secretion in pigs. (1978) (5)
Differentiation of PC12 Cells Results in Enhanced VIP Expression and Prolonged Rhythmic Expression of Clock Genes (2008) (5)
Spatiotemporal expression pattern of PERIOD 1 and PERIOD 2 in the mouse SCN is dependent on VIP receptor 2 signaling (2019) (5)
Role of light and the circadian clock in the rhythmic oscillation of intraocular pressure: Studies in VPAC2 receptor and PACAP deficient mice (2018) (5)
Co-existence of peptides and classical neurotransmitters in autonomic regulation of blood flow and exocrine secretion (1984) (4)
Sympathetic nerve activation decreases the release of vasoactive intestinal polypeptide from the feline intestine. (1986) (4)
PKA, novel PKC isoforms, and ERK is mediating PACAP auto-regulation via PAC1R in human neuroblastoma NB-1 cells (2016) (4)
Presence of PACAP‐Immunoreactive Neurons in the Trigeminal Ganglion of the Sheep: Indications for a Trigeminal Innervation of the Pineal Gland (2000) (4)
The Light‐Induced FOS Response in Melanopsin Expressing HEK‐293 Cells is Correlated with Melanopsin Quantity and Dependent on Light Duration and Irradiance (2014) (4)
VIP (Vasoactive Intestinal Polypeptide) — immunoreactive innervation of the portal vein (2004) (4)
Secretion of pancreastatins from isolated, perfused, porcine adrenal glands (1994) (4)
Influence of pregnancy and sex steroids on concentration, motor effect and receptor binding of VIP in the rabbit female genital tract (1985) (4)
Altered light induced EGR1 expression in the SCN of PACAP deficient mice (2020) (4)
MAXIMAL ACID OUTPUT AND RISK OF ULCER (1977) (4)
Association between hair cortisol concentration and dietary intake among normal weight preschool children predisposed to overweight and obesity (2019) (4)
Circadian rhythms and food anticipatory behavior in Wfs1-deficient mice. (2012) (4)
Neurotransmitter-role of VIP in non-adrenergic relaxation of feline myometrium (1985) (4)
Functional Implications of Coexistence of Peptides and Classical Transmitters: Studies on Exocrine Glands (1982) (4)
Plasma beta-endorphin during clinical and experimental ischaemic pain. (1987) (4)
Nervous control of pancreatic endocrine secretion in pigs. IV. The effect of somatostatin on the insulin and glucagon responses to electrical vagal stimulation and to intraarterial acetylcholine. (1981) (4)
Neurochemical phenotype of cytoglobin-expressing neurons in the rat hippocampus. (2014) (4)
Diurnal gene expression of lipolytic natriuretic peptide receptors in white adipose tissue (2015) (3)
A Model of the Receptors in the VIP Receptor Family (1998) (3)
Vasoactive Intestinal Polypeptide/Peptide Histidine Isoleucine‐Immunoreactive Neuron Systems in the Basal Hypothalamus of a Rat Strain with Deficient Prolactin Release in Response to Stress (1992) (3)
Downregulation of VPAC1R Expression in Breast Cancer Cell Lines (2000) (3)
Characterization and regional distribution of prepro-VIP derived peptides in the normal human brain and gut (1989) (3)
Gastrointestinal endocrinology. (1996) (3)
VIP-IMMUNOREACTIVE AND PHI-IMMUNOREACTIVE PEPTIDES IN THE TAPEWORM, MONIEZIA-EXPANSA - CHROMATOGRAPHIC CO-ELUTION WITH OVINE (HOST) AND PORCINE ANALOGS (1990) (3)
VIP is released in the anal direction of a distension in the cat small intestine (1983) (3)
PACAP in the Urogenital Tract (2003) (3)
Effect of ganglionic blockade on endogenous circulating pancreatic polypeptide, vasoactive intestinal polypeptide, substance P, neurotensin and noradrenaline in healthy controls and long-term insulin-dependent diabetic patients. (1986) (3)
Secretion pattern ofsecretin inman:regulation by gastric acid1 (1978) (3)
Postprandial Portal Venous Blood Flow and Portal Plasma Vasoactive Intestinal Peptide in Man (1988) (3)
Regulation of prepro-VIP expression in the human neuroblastoma cell line NB-1 (1992) (2)
Neuropeptides and their Possible Role as Auxiliary Messengers (1986) (2)
VIP as neurotransmitter in the female genital tract (1983) (2)
Mitochondrial Function / Dysfunction in Health and Disease Temporal phasing of locomotor activity , heart rate rhythmicity , and core body temperature is disrupted in VIP receptor 2-deficient mice (2011) (2)
Vasoactive intestinal polypeptide in cerebrospinal fluid of patients with dementia (1985) (2)
BRAIN PEPTIDES IN PSYCHIATRIC DISORDERS (1984) (2)
Secretin release in man: current status. (1978) (2)
Oxytocin and vasopressin release by vasoactive intestinal polypeptide (VIP) in normal women (1988) (2)
Immunohistochemical demonstration of vasodilatory peptidergic nerves in brain. (1977) (2)
Cholecystokinin- and VIP-containing pathways in the rat brain (1980) (2)
[Electric stimulation of the autonomic nervous system and vasoactive intestinal peptide and substance P release on the lower esophageal sphincter]. (1990) (1)
Immunohistochemical demonstration of vasodilatory peptidergic nerves in brain. (1977) (1)
Vasoactive Intestinal Peptide (2011) (1)
Pituitary Adenylate Cyclase Activating Peptide (PACAP) Signalling in the Pupillary Light Response (2009) (1)
Multiple Functions of Peptides: Insulin and Vasoactive Intestinal Polypeptide Bind to Receptors in Liver and Brain (1982) (1)
Gastrointestinal effect of calcitonin: Inhibition of gastrin secretion (1975) (1)
The Circadian Clock Is Sustained in the Thyroid Gland of VIP Receptor 2 Deficient Mice (2021) (1)
Effect of kainic acid injections and other brain lesions on vasoactive intestinal peptide (VIP)-stimulated formation of cAMP in rat brain (1979) (1)
On the role of PHI and VIP in neuroendocrine function (1989) (1)
VIP and the urogenital system (1985) (1)
Expression of pro-VIP in eukaryotic cells in studies on posttranslational modifications (1992) (1)
VIP receptors in hog liver cells. Degradation of bound VIP and different binding characteristics compared with other tissues (1983) (1)
Evidence for VIP as the neurotransmitter in vasodilator mechanisms of the feline small intestine and colon (1983) (1)
Immunohistochemical assessment of PACAP and its receptor PAC1 in the gastric and colonic enteric nervous system in rat (2000) (1)
Coexistence of PHI and VIP in peripheral autonomic neurons (1983) (1)
Release of vasoactive intestinal polypeptide (VIP) in breast-feeding women. (1986) (1)
VIP and PACAP receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (1)
Receptors for VIP are present on purified choroid plexus epithelial cells (1989) (1)
CURRENT KNOWLEDGE OF THE STORAGE AND RELEASE OF TRANSMITTER CANDIDATE AMINO ACIDS AND NEUROPEPTIDES (1980) (1)
VIP, PACAP, GLUCAGON, and related peptides : Fourth International Symposium (2000) (1)
Non-amidated forms of VIP (glycine-extended VIP and VIP-free acid) have full bioactivity on smooth muscle (1989) (1)
VIP increases local vaginal blood flow in women after subepithelial application (1989) (0)
Peptidergic Innervation of Blood Vessels In The Urogenital System (2019) (0)
VIP stimulates prolactin release in women [letter] (1981) (0)
Retina Loss of Melanopsin-Expressing Retinal Ganglion Cells in Patients With Diabetic Retinopathy (2017) (0)
Effects of PHI and VIP on neurohypophyseal release (1989) (0)
Diurnal gene expression of lipolytic (2015) (0)
Circulating VIP in patients with uraemia and liver cirrhosis (1985) (0)
RECEPTORS FOR VASOACTIVE INTESTINAL POLYPEPTIDE (VIP) IN NERVE-ENDINGS FROM RAT BRAIN (1981) (0)
Radioimmunoassay of Beta‐endorphin. Methodological Aspects and Plasma Beta‐endorfin in Migraine (1984) (0)
Immunohistochemical localization of PACAP and its receptor, PAC1, in the gastric and colonic enteric nervous system (2000) (0)
Abstracts: 4th International Symposium On VIP, PACAP, Glucagon And Related Peptides Elsinore, Denmark: September 1-4, 1999 (1999) (0)
VIP as neurotransmitter in penile erection (1983) (0)
Immunoreactive Trypsin andPancreatic Isoamylase Activity inSerumof Patients withChronic RenalFailureorHepaticCirrhosis (1981) (0)
Vasoactive Intestinal Polypeptide ( VIP ) in Epithelial Cells of the Gut Mucosa of an Elasmobranchian Cartilaginous Fish , the Ray STURE FALKMER 1 * , (2010) (0)
[Peptides and human reproduction]. (1984) (0)
Interactions between VIP and acetylcholine in relation to vasodilation and exocrine secretion (1983) (0)
Mice Lacking EGR1 Have Impaired Clock Gene (BMAL1) Oscillation, Locomotor Activity, and Body Temperature (2017) (0)
Expression of the clock genes Per1 and Bmal1 during follicle development in the rat ovary. Effects of gonadotropin stimulation and hypophysectomy (2012) (0)
[Verner-Morrison syndrome]. (1981) (0)
Circadian clock components in the rat neocortex: daily dynamics, localization and regulation (2012) (0)
Retinoic Acid Regulates preproVIP Expression in the Human Neuroblastoma Cell Line NB-1 (1993) (0)
PHM and VIP in the human female genital tract: Occurrence and relaxant effect (1989) (0)
Expression and characterization of VIP NIH 3T3 cells and two VIP mutants in (1994) (0)
Transfection of trigeminal sensory and motor neurons by adenoviral vectors containing GFP and Bcl-2 constructs in neonatal mice (2002) (0)
Ontogeny of VIP binding sites in cerebral cortex and cultured neurons from mice (1985) (0)
Preface (2000) (0)
P.2.a.009 Disturbances of circadian rhythm in a rat chronic mild stress model of depression (2014) (0)
[The brain's biological clock]. (2018) (0)
Vasoactive intestinal polypeptide (VIP) in cerebrospinal fluid of patients with multiple sclerosis (1983) (0)
VIP receptors on synaptosomes from rat cerebral cortex: Structure-binding relationship (1985) (0)
[Diagnostic measurements and diurnal rhythms]. (2018) (0)
Altered Rhythm of Adrenal Clock Genes, StAR and Serum Corticosterone in VIP Receptor 2-Deficient Mice (2012) (0)
Concentrationof ImmunoreactiveTrypsinand Activityof Pancreatic Isoamylasein Serum Compared in PancreaticDiseases (2004) (0)
Syddansk Universitet Diurnal Variations of Human Circulating Cell-Free MicroRNA Heegaard (2016) (0)
Plasticity of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type-1 receptor expression in regenerating superior cervical ganglia (1996) (0)
Vasoactive intestinal polypeptide and neurological diseases (1989) (0)
Nervous release of VIP from the feline uterus: Pharmacological characteristics (1983) (0)
Circadian phenotype of double mutant PAC1/VPAC2 receptor knockout mice (2012) (0)
Receptors for vasoactive intestinal polypeptide in hepatocytes isolated from rat or pig (1980) (0)
[Neuropeptides in health and disease]. (1985) (0)
Localization of neurons immunoreactive to VIP, PHI and fragments of prepro-VIP in the central (CNS) and peripheral nervous system (PNS). Co-existence of VIP and PHI in synaptic vesicles (1989) (0)
VIP and PHI: Localization and comparison between vascular and smooth muscle effect in the rabbit female uro-genital tract (1985) (0)
intestine exposed to cholera toxin . polypeptide from the cat small Release of vasoactive intestinal (0)
The Complex Kinetics of Insulin Binding to Receptors on Isolated Pig Hepatocytes (1982) (0)
[A newly discovered photopigment in the retina, melanopsin, directs the biological clocks of the brain]. (2002) (0)
Radioimmunoassay of Gut Regulatory Peptides edited by Stephen R. Bloom and Richard G. Long, W. B. Saunders Company Ltd, 1982. £10.50 (i + 194 pages) ISBN 0 721 61750 6 (1983) (0)
[Vasoactive intestinal polypeptide and sexual function: inhibition of motility in the fallopian tubes and uterus. Positive role in penile erection]. (1985) (0)
Acid, food, and secretin (1978) (0)
Temporal Expression of natriuretic receptors in adipose tissue associated with diurnal lipolysis (2014) (0)
Basal hyperchlorhydria and its relation to gastrointestinal hormones during prolonged strain in man (1983) (0)
[Neuropeptides in health and disease]. (1985) (0)
Advanced rhythm of adrenal clock genes, StAR and serum corticosterone in VIP receptor 2 deficient mice (2012) (0)
Pituitary adenylate cyclase-activating polypeptide is an auto/paracrine stimulator of acute progesterone accumulation and subsequent luteinization in cultured periovulatory granulosa/lutein cells. (1999) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Janj Fahrenkrug?

Janj Fahrenkrug is affiliated with the following schools:

University of Copenhagen
Karolinska Institute